Related Experiment Video
Updated: Aug 15, 2026

Training a Sophisticated Microsurgical Technique: Interposition of External Jugular Vein Graft in the Common Carotid Artery in Rats
Published on: November 11, 2012
Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention
1Department of Cardiology, Cleveland Clinic Foundation, Ohio, USA.
Insights
Saphenous vein graft disease is a major challenge after bypass surgery, caused by thrombosis and atherosclerosis. Prevention strategies include surgical improvements, better antiplatelet drugs, and aggressive risk factor management.
Area of Science:
- Cardiology
- Vascular Surgery
- Cardiovascular Disease
Background:
- Aortocoronary saphenous vein graft disease poses significant clinical challenges.
- Graft failure occurs due to thrombotic occlusion (early) and atherosclerotic obstruction (late), exacerbated by neointimal hyperplasia.
- Vein grafts exhibit inherent deficiencies when adapted to the arterial circulation, amplifying risk factor effects.
Purpose of the Study:
- To review the pathophysiology of saphenous vein graft disease.
- To discuss emerging prevention and treatment strategies.
- To highlight the importance of arterial conduits in coronary bypass surgery.
Main Methods:
- Literature review of current understanding of vein graft disease.
- Analysis of risk factors and pathobiological mechanisms.
- Evaluation of evolving therapeutic interventions and surgical choices.
Main Results:
- Vein graft attrition is driven by thrombosis and atherosclerosis.
- Risk factors for native coronary disease are amplified in vein grafts.
- Multifaceted prevention strategies are emerging, including surgical techniques, antiplatelet therapy, risk factor modification, and novel therapies.
Conclusions:
- Saphenous vein graft disease requires comprehensive management strategies.
- Arterial conduits, such as internal mammary arteries, are preferred to circumvent graft disease.
- Early and aggressive lipid-lowering therapy is a key component of prevention.
Abstract:
Aortocoronary saphenous vein graft disease, with its increasing clinical sequelae, presents an important and unresolved dilemma in cardiological practice. During the 1st month after bypass surgery, vein graft attrition results from thrombotic occlusion, while later the dominant process is atherosclerotic obstruction occurring on a foundation of neointimal hyperplasia. Although the risk factors predisposing to vein graft atherosclerosis are broadly similar to those recognized for native coronary disease, the pathogenic effects of these risk factors are amplified by inherent deficiencies of the vein as a conduit when transposed into the coronary arterial circulation. A multifaceted strategy aimed at prevention of vein graft disease is emerging, elements of which include: continued improvements in surgical technique; more effective antiplatelet drugs; increasingly intensive risk factor modification, in particular early and aggressive lipid-lowering drug therapy; and a number of evolving therapies, such as gene transfer and nitric oxide donor administration, which target vein graft disease at an early and fundamental level. At present, a key measure is to circumvent the problem of vein graft disease by preferential selection of arterial conduits, in particular the internal mammary arteries, for coronary bypass surgery whenever possible.
More Related Videos
09:04Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
Published on: November 19, 2019
07:02A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
Published on: May 15, 2020
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Peripheral Artery Disease V: Postoperative Nursing Management
Varicose Veins I: Introduction
Venous Thrombosis I: Introduction